Caisson Biotech

An Emergent Company

  • Home
  • About Us
    • History / Timeline
    • Team
  • Technology
    • What is HEPtune?
    • What is HEPboost?
    • About Heparosan
    • HEPtune Advantages
    • Heparosan as a Drug Delivery Vehicle
    • Applications
  • Partnering
  • News
    • Press Releases
    • Articles
  • Contact Us

Press Releases

February 23, 2021 – Caisson Biotech, LLC & Heparinex, LLC Announce Positive Examination Report of European Patent and the Discovery of a New Class of Sugar Polymers
February 13, 2019 – Emergent Technologies, Inc. Hires Steven Lloyd Mayer, MD as Chief Medical Officer and Promotes Blake Harlan to Executive Vice President Finance and Operations
April 8, 2015 – Caisson Biotech Wins Innovation Recognition Award
March 11, 2014 – Caisson Biotech Expands HEPtune™ Drug Delivery Deal with Novo Nordisk
May 1, 2013 – Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
May 1, 2012 – Caisson Biotech Enters Into Development and License Agreement with Novo Nordisk
July 23, 2012 – Caisson Biotech, LLC Appoints Biotechnology Veteran Glenn Nedwin CEO and President

News

  • News
  • Press Releases
  • Articles

Copyright © 2025 · Caisson · Site by RTL Digital Media, LLC

Copyright © 2025 · Enterprise Pro Theme on Genesis Framework · WordPress · Log in